Drug
Exenatide Synthetic
Exenatide Synthetic: highest development phase Approved, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| BYETTA | Approved |
Latest
No recent events.
Follow Exenatide Synthetic on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.